Cello Group (CLL)

 

CLL Share PerformanceMore

52 week high128.00 11/04/17
52 week low91.75 05/05/16
52 week change 23.00 (23.47%)
4 week volume4,448,309 28/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Annual Report and notice of Annual General Meeting

RNS Number: 4906C Cello Group plc 13 April 2017 For Immediate Release 13 April 2017 Cello Group plc Annual Report and notice of Annual General Meeting Cello Group plc announces that the Notice of Annual General Meeting ("AGM Notice"), form of proxy and Annual Report and Accounts for the year ended 31 December 2016 ("Annual Report") have been pos...

Block listing Interim Review

RNS Number: 5901B Cello Group plc 04 April 2017 Cello Group plc ("Cello" or the "Company") Block Listing Update Further to the announcement by the Company on 9 September 2016, the Company announces that a total of 562,009 ordinary shares of 10p each in the share capital of the Company ("Ordinary Shares") have been issued since that date pursuant to the ...

Total Voting Rights

RNS Number: 1705B Cello Group plc 31 March 2017 Cello Group plc Total Voting Rights In conformity with the FCA's Disclosure and Transparency Rules, Cello Group plc ("Cello" or the "Company") confirms the following: As at 31 March 2017 Cello's issued share capital consists of 103,690,894 ordinary shares of 10 pence each ("Ordinary Shares"). The Company holds ...

Holding(s) in Company

RNS Number: 7904A Cello Group plc 28 March 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii CELLO GROUP PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisi...

Broker Forecast - N+1 Singer issues a broker note on Cello Group PLC

N+1 Singer today reaffirms its buy investment rating on Cello Group PLC (LON:CLL) and set its price target at 131p.

Cello revenues rise

Pharmaceutical and consumer strategic marketing group Cello's revenue rose 5.4% to 165.3m in the year to the end of Decem...

Preliminary Results

RNS Number: 1354A Cello Group plc 22 March 2017 For Immediate Release 22 March 2017 Cello Group plc ('Cello' or the 'Group') Preliminary Results for the twelve months ending 31 December 2016 Strong 2016 performance - robust gross profit growth. Cello Group plc (AIM:CLL, "Cello" or "the Group"), the pharmaceutical and consumer strategic marketing group, ...

Holding(s) in Company

RNS Number: 4535X Cello Group plc 21 February 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii CELLO GROUP PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisi...

Fundamental DataMore

EPS-3.23
Dividend yield2.81 %

Latest discussion posts More

  • 500k

    Wow, that's two 250 trades gone through, and the sp holds steady - up now. Hmm, glad I'm holding. Maybe that should have been a Buy rec...
    22-Mar-2017
    Lupo di mare
  • Re: Results

    Just as well I wasn't expecting anything too dramatic ;). Everything seems to be ticking along nicely. Seems like they''ve decided that they need to grow by acquisition. ...
    22-Mar-2017
    Lupo di mare
  • Results

    Preliminaries tomorrow, chaps and chapesses. I'm not expecting anything dramatic, but...
    21-Mar-2017
    Lupo di mare

Users' HoldingsMore

Users who hold Cello Group also hold..
LLOYDS GRP.35%
ROYAL BANK SCOT29%
BP22%
RDS 'B'22%
GLAXOSMITHKLINE21%

Codes & Symbols

ISINGB00B0310763
SymbolsCLL, LSE:CLL, CLL.L, CLL:LN, LON:CLL, XLON:CLL